Nektar Therapeutics
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $1.08B | $199.0M |
| FY2021 | — | $679.5M | $25.2M |
| FY2022 | — | $366.6M | $88.2M |
| FY2023 | — | $131.0M | $35.3M |
| FY2024 | — | $60.7M | $44.3M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $1.08B | $199.0M |
| FY2021 | — | $679.5M | $25.2M |
| FY2022 | — | $366.6M | $88.2M |
| FY2023 | — | $131.0M | $35.3M |
| FY2024 | — | $60.7M | $44.3M |